CompaniesByCap
OGEN
Oragenics Inc. (OGEN)
NYSE · Healthcare

Oragenics Inc. Cash Flow 2010–2023

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2012Dec 2011Dec 2010
Operating Activities
Operating Cash Flow-9.2M-8.6M-7.3M-15.2M-13.5M-17.0M-13.0M-9.1M-6.4M-7.1M-5.2M-5.2M-5.5M-6.4M
Depreciation & Amort.27,39144,66741,23751,70562,62230,11065,80375,04471,15275,19079,51642,735
Investing Activities
Capital Expenditure127,51943,87625,214124,72727,179102,51111,09588,084
Free Cash Flow-15.4M-13.5M-13.0M-9.2M-7.1M-5.3M-5.2M-6.5M
Financing Activities
Dividends Paid
Stock Buybacks3,751

Oragenics Inc. Cash Flow — FAQ

Oragenics Inc. (OGEN) cash flow over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see OGEN's cash flow history?

The chart and table above show Oragenics Inc.'s cash flow by year and by quarter, including the growth rate.